When tumor cells expressing PD-L1 bind to T cells expressing PD-1, they can relieve the inhibition of T cells, restore their killing activity, increase the proliferation of CD8+ T cells and IFN-γ secretion, and enhance cytotoxicity. The gene discussed is IFNG; the disease is neoplasm.